cross-talk a big pharma i'm joined by david healy in bangor he is a professor of psychiatry at cardiff university and author of the book farmageddon we also have martha rosenberg in chicago she's an investigative health reporter in author of born with a junk food deficiency and in new york we cross to josh blum he's director of chemical and pharmaceutical sciences at the american council on science and health all right crosstalk rolls in effect that means you can jump in anytime you want david if i go to you first is the western world over pharmac aided if i can use that term. yes it is using more and more drugs for conditions that we don't need to read treatments for but we need our drugs to work well for conditions we do need treatment for and the pharmaceutical industry is less and less able to produce the kind of treatments that we need at the moment on the. so if you and if you hoed shares in any of the problems that accompanies you doing quite well because they could make massive profits out of selling treatments that on particular you needed to us recently josh how do you respon

it's not like the other big pharma come bennies are blind to what's happening here.y know they need to find new sources of growth and a smart biotech acquisition could be the way to do that. the chairman of novartis said, and i point, consider a $10 billion purchase among other options for bolstering the business. there are a bunch of players who could afford to do a $10 billion biotech acquisition. we know pfizer is rumored to be interested in onyx. now they'll have to find something else to buy. merck could afford it, so could j and j or glaxo smith kline, sanofi, bristol-myers or bayer, and all of them would benefit from some transaction, which brings us to the key question, who is next. when i say who is next i'm not referring to the seminal album by the who, although i bet that pete townsend did a great job in that won't get fooled again. i saw it last year. we want to find out which of the smaller biotech's will get snapped up and given that $10 seems to be the magic number on the what amgen paid for onyx and what iliad paid and what novartis said they would sh

their kids to school that sounds like a good idea to me by a blow to the big board you just want big pharma to invade russia i mean look you know reporters shoot yourself in the foot because you can't export nobody is competitive the world is no organized along global value chains and you do one of the links of the global value chain russia or any other country in the world it has nothing to do with russia it is the way the whole production in the world is or going full circle here we're all talking about and. then i have to have to correct you it's a question of security as well you are going to put the disposal of vaccines where we we i'm saying now we can choose whether we give these vaccines to america doesn't produce a mile over to russia well security is a very strange birth we don't need to go i'm not really sure if you smoke or tourist in the us better. the inefficiency on sawrey way indication but real progress on the road i'm sorry you know we can all live in a dream world but we do not believe in one country and come to. a competitive security. and will remain a very important th

their kids to school that sounds like a good idea to me by bloggers in big words you just want big pharma to invade russia i mean look you know reporters shoot yourself in the foot because you can't export nobody is competitive the world is no organized along global value chains and you do one of the links of the global value chain russia or any other country in the world it has nothing to do with russia it is the way the whole production in the world is or going full circle here we're all talking about it and then i have to have to correct you it's a question of security as well you are going to put the disposal of vaccines where we we i'm saying now we can choose whether we give these vaccines to america doesn't produce a mile over to russia where security is a very strange birth we don't need to go through. a few smokers who are doing just . the inefficiency on sawrey way indication but real progress on the road i'm sorry you know we can all live in a dream world but we do not believe in one country and come to be competitive security and will remain a very important thing but you. see

that's pretty dangerous you've got a lot of success your comedy roasts and everything to you as this big pharma from nebraska do you have a pinch yourself every day and you did it right i do every day it's the most incredible thing and that's that's why i'm glad i'm only in america i myself i'm like an american that's nori you know i mean i just this kid growing up in pony's city nebraska and united and i found a career that i thought i enjoyed you like pigs love them yeah oh yeah well before we go to break what's a special thing we don't know about pigs pigs are the smartest barnyard animal there is and is more of a. pig you can train a pig to do anything i'm not kidding a pig is my alltime and they're lovable and they're godly and you really can't you get a mess around in dirt why and who doesn't know you got a point once in a thing like must run and there. was a jewish guy from new york the best around in dirt over once in a breast and always in the breast and larry on why he won't leave the corner house just eight plus daniel maybe larry sounds obama comics next maybe i'll turn into elizabe

the nuclear companies, when we cover the health care debate in this country not brought to you by big pharma, the drug companies or the insurance industry. but brought to listeners and viewers my listeners and viewers who feel that information is power, information is essential, it is the oxygen of a democracy. >> host: back to the exception to the rulers. our motto at democracy now is to break the sound barrier. we call ourselves to the exception to the rulers, we believe all media should be. what do you mean by sound barrier? >> so often on the networks we get this small circle of pundits who knows so little about so much, explaining the world to us and getting it so wrong. we go to the communities to talk to people in this country and around the world who learned the hard of the story. it is not easy to find the people sense authentic voices. that is why so many young people listen to democracy in all. we have a diverse audience in this country and around the world because people know in what they're talking about because they're talking from their own experience. that is the best kind of

breaking the law drug dealers who push pot can't write off their lawyers fees but drug dealers a big pharmaeven when they lie and break the law in ways that kill people something pot's never done can write off those lawyer fees all because they're incorporated all these breaks come in exchange for the company receiving those benefits giving society something back in return besides a useful service like selling meals or a good product like a well made car the single most important thing a business owner can give back to society is well paying jobs with benefits a job that pays a living wage isn't just good for the workers who get to take home a livable paycheck it's good for other business owners and the economy as a whole businesses need people with reasonable incomes to buy their goods and workers are paid so little that they can barely afford to eat they can't spend additional money and as a result the entire. economy suffers this is econ one hundred one that implicit contract between society and the business owner used to be common knowledge in this country until the reagan revolution wa

>>> and from a big pharma name that's flying to a travel company that's dropping. we've got your winning and losing trades in today's biggest movers. stick around. lot more "half" is on the way. clients are always learning more to make their money do more. (ann) to help me plan my next move, i take scottrade's free, in-branch seminars... plus, their live webinars. i use daily market commentary to improve my strategy. that's flying to a travel ning every step of the way. because they know i don't trade like everybody. i trade like me. i'm with scottrade. (announcer) scottrade... ranked "highest in customer loyalty for brokerage and investment companies." that's flying to a travel >>> all right. the drama at jcpenney continuing today. activist investor bill ackman resigning from the board of directors. i spoke with former ceo allen questrom just a few moments ago who told me that mr. ackman has done the right thing. he also put his support behind the gentleman who was named to the board who was a former vice chairman of fed rated. so this story has new developments.

american scholars 2011 the title is lacking for big pharma. very objective title. >> thank you very much. more and then you expected. >> thank you very much. my question is in relation to informed consent. .. >> the patents -- >> oh. >> yes. >> um, i think the last question first is easier. patents should not be banned, but they should be much more strictly controlled. and, in fact, that's what most other countries do. they permit patents, but they do not permit as many patents as we do. they don't permit a 20-year patent life which a company can easily extend by various, you know, manipulations. we have too many patted edges covering too many things -- patents covering too many things, and we allow them to persist for too long. they need to be tightly reined-anyone and controlled. a company holds a patent on a medication but they are making the medication at too high a price, $20,000 a year, or if they are not making the medication but holding the patent so nobody else can make it, then there is a regulation that says the government can step

, and then it drifts back, because the needle to move big pharmaso, so impossible. so this is a cheap stock and if it went to $54, i'm buying. >> and now are we going into a new aer ra of innovation rather than patent protection of introducing a new it ration of a patented drug? >> no, they are cutting, cutt g cutting, cutting, and outsourcing the tests. j&j, and gor ski said we are spending billions to test the drugs and let's hand it off to the guys who can do a test for much more quick ly and easily ad inexpensive. so i am saying that big pharma has been dormant, but they have a lot of stuff working, but a lot of it is harvesting the last stage stuff and not do the basic. >> we talk about how the big market techs are going to have gilead. let's move on the bp. >> everybody has to recognize that dudley who is the ceo, and people feel that he was snookered by the u.s. government and micking a big deal with the justice department, and while the ink is the drying, the epa sue sues him. he has full page ads saying, what do we have to do to please lou

american scholars 2011 the title is lacking for big pharma. very objective title. >> thank you very much. more and then you expected. >> thank you very much. my question is in relation to informed consent. .. >> the patents -- >> oh. >> yes. >> um, i think the last question first is easier. patents should not be banned, but they should be much more strictly controlled. and, in fact, that's what most other countries do. they permit patents, but they do not permit as many patents as we do. they don't permit a 20-year patent life which a company can easily extend by various, you know, manipulations. we have too many patted edges covering too many things -- patents covering too many things, and we allow them to persist for too long. they need to be tightly reined-anyone and controlled. a company holds a patent on a medication but they are making the medication at too high a price, $20,000 a year, or if they are not making the medication but holding the patent so nobody else can make it, then there is a regulation that says the government can step

do you invest in the little companies on the hope they'll have a big-hit product, or do you invest in the large cap pharmauy some of the biotech companies? >> you do a combination of both. that's a great question. this is binary space. you have the emerging biotech companies that will either make it or not, going from phase two to phase three, hopefully not have a daefrt come phase three time. there's been a big change at the fda since new regulations last summer, so more communication during the process. you want to look at this as a basket approach. balance it out. you want some of the large $80 billion gilead, amgens and mix in there the sub-500 smaller caps that will be the ten-baggers and play with the etf with 20 or 100 bets or a mutual fund, or develop your own basket. but spread out the risk such that you're not putting your eggs in one biotech company. >> what about you, brett? what's the winning sector for the next five years? >> i think technology. mandy, i want to dress the part, so i worn casual, even the one-day growth on the beard, so he look like a tech guy. >> a hip ster. >> all right. >>

pharma has contracted. >> and you want to talk about deere, because big macro call on deere out of william blair this timeerformed and the price target is 75. we don't have a major contention with deere they say, but they think that farm machinery in north america next year down 10 and down 10 the next year and additional downside risk on top of that. >> well, it is actually amazing, because the farm economy is in a boom, and i dont n't know if th got caught in the machinery and overbuying or what, but this is the analysts overperforming the stocks by the way. >> i want to stop your serious conversation about farm machinery to get to ashton kutcher who is near bob pisani. >> we are standing here on the side. >> i know that bob is trying to get there. bob, do you have the mike on? >> i do. they are saying that they don't want me to talk to him actually. he is not doing interviews. that is the whole point. >> and wondering. make making the traditional stop at the telephones between post 8 and 9. it is interest, because we get a lot of actors in here, but not one who has caused a stir as much as kutcher has.